From Physician to Biotech CEO: Building High-Impact Clinical Development with Dr. Allison Jeynes

In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Allison Jeynes, CEO of Nefro Avillion Clinical Development, to explore her remarkable journey from clinician to biotech leader. With over 30 years of experience and a track record that includes the development and approval of nearly 20 drugs, Allison shares how she built a 100% success-rate model in clinical development, and what it takes to sustain excellence in a high-risk industry. Clinical Trialblazers is back for Season Two. Host Alberto Grignolo speaks with Paul Garofolo, Co-Founder and CEO of Locus Biosciences, about the leadership mindset behind capital efficiency, resource prioritization, and disciplined execution. Drawing on Paul’s journey from global leadership roles at Patheon to founding a next-generation precision medicine company, this episode explores fundraising across market cycles, founder-friendly capital, strategic and government partnerships, and the science behind Locus’ bacteriophage-based platform aimed at tackling multidrug-resistant infections.